Psychosocial difficulties related to brain disorders much more similar than expected
Do you have difficulties remembering to do important things? A sense of everything moving too fast around you? Problems getting through the day because you just do not have the energy? The various illnesses that can have an impact on the brain may not have a lot in common, but patients may well struggle with similar problems in daily life, to varying degrees.
The EU-funded PARADISE project explored such commonalities in difficulties of this nature – i.e. psychosocial problems – reported by people with brain disorders. Using a protocol developed by the consortium, research revealed that there are, indeed, similarities, says Alarcos Cieza, who led the project on behalf of Ludwig-Maximilians-Universität Munich, Germany.
Generally speaking, psychosocial difficulties associated with brain disorders tend to be much more similar than expected, although the underlying diseases can be very different. Improved understanding of these similarities across different disorders can now help to direct interventions with proven effectiveness at a much wider range of patients, Cieza adds.
By way of example, the nature and impact of the psychosocial difficulties like loneliness and helplessness, faced by someone going through severe depression, for instance, may well overlap with those of a person living with multiple sclerosis (MS). Interventions designed to support individuals affected by one particular brain disorder, such as boosting their ability to carry out daily activities despite a diagnosed MS, might also benefit patients suffering from, for example, severe depression which also often leads to neglect of daily life requirements.
Cataloguing commonalities
'We know that there is a specific burden associated with neurological conditions and psychiatric conditions, in terms of their impact on people's lives,' says Cieza. 'But currently, research still tends to look at each of these conditions in separation to assess this burden. The commonalities are rarely considered. We have come to realise that this is not an efficient way to approach the major public health disease burden in our populations.'
The project, which ended in June 2013, conducted a comprehensive literature review to take stock of the various psychosocial problems reported individually for dementia, depression, epilepsy, migraine, multiple sclerosis, Parkinson's disease, schizophrenia, stroke, and substance-use disorders.
Then, 24 core questions were selected from a wider protocol underpinning a new study that involved 800 participants. Each of the questions targeted a specific aspect related to the perceived disease burden, inviting respondents to rate the extent of any problems they might have encountered. Topics included psychosocially relevant difficulties as varied as impaired memory function, reduced coping or decision-making abilities, and difficulties engaging with others.
PARADISE in practice
The PARADISE project enabled the researchers to confirm very substantial commonalities of disease burden induced by the different psychiatric and neurological disorders, as Cieza notes. The resulting PARADISE-24 protocol is now widely available to clinicians and researchers to measure psychosocial difficulties independently of the underlying illness.
'Before, there was no instrument that looked at the burden of neuropsychiatric conditions in general,' she says, adding that it can also be used to assess the public health impact of interventions targeting psychosocial difficulties.
Growing awareness of these similarities is helping to change the way researchers, and hopefully also physicians, think about the psychosocial challenges associated with brain disorders. The PARADISE-24 protocol is already used in regular clinical practice by a number of partners who were involved in the project, Cieza adds.
The underlying concept – which she refers to as 'horizontal epidemiology' – in fact also inspired a new wave of research. By way of example, it was further explored in the EU-funded MARATONE project, a training network for early-stage researchers that was backed by the EU's Marie Skłodowska-Curie actions programme.
.png)
No hay comentarios:
Publicar un comentario